-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Maintains Outperform on TrueBlue, Lowers Price Target to $6

Benzinga·11/05/2025 13:14:03
Listen to the news
BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and lowers the price target from $8 to $6.